Product Information
DULOXETINE HCL DR 60 MG CAP is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1349 per EA under NDC 82009003210. Its NADAC has been published 190 times since Feb 15, 2023.
FDA first approved this application on Jun 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009003210
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203088FDA Approved
6/11/2014
TE Code
AB
On Market Since
6/11/2014
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 60 MG CAP has been published 190 times since Feb 15, 2023, and over the history we have for it it has risen 20.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1349 per EA |
|---|---|
| All-time high | $0.1349 (Sep 30, 2026) |
| All-time low | $0.0840 (Nov 20, 2024) |
| 52-week high | $0.1349 |
| 52-week low | $0.0929 |
| Median price | $0.1105 |
| Average price | $0.1079 |
| Largest weekly change | -18.3% (Nov 20, 2024) |
| Weeks tracked | 190 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quallent Pharmaceuticals Health LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DULOXETINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 60 MG CAP, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1349 per EA (NDC 82009003210), effective Sep 30, 2026.
How has the price of DULOXETINE HCL DR 60 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 60 MG CAP has risen 20.5%. It has been tracked across 190 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 60 MG CAP?
Since Feb 15, 2023, the NADAC for DULOXETINE HCL DR 60 MG CAP has ranged from a low of $0.0840 (Nov 20, 2024) to a high of $0.1349 (Sep 30, 2026), with a median of $0.1105 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 60 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 60 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 60 MG CAP?
DULOXETINE HCL DR 60 MG CAP (NDC 82009003210) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.